Virtu KCG Holdings’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$611K Sell
28,478
-13,992
-33% -$282K 0.02% 959
2017
Q1
$728K Sell
42,470
-65,194
-61% -$1.14M 0.02% 996
2016
Q4
$1.93M Sell
107,664
-180,474
-63% -$3.27M 0.05% 331
2016
Q3
$5.99M Buy
288,138
+263,382
+1,064% +$6.53M 0.14% 61
2016
Q2
$666K Sell
24,756
-60,788
-71% -$1.67M 0.01% 1089
2016
Q1
$2.32M Sell
85,544
-98,846
-54% -$2.65M 0.07% 225
2015
Q4
$5.36M Buy
184,390
+140,048
+316% +$3.88M 0.09% 131
2015
Q3
$1.2M Sell
44,342
-2,908
-6% -$82.3K 0.02% 735
2015
Q2
$1.29M Sell
47,250
-66,466
-58% -$1.87M 0.02% 656
2015
Q1
$3.04M Sell
113,716
-427,474
-79% -$9.84M 0.06% 231
2014
Q4
$11.5M Buy
541,190
+537,006
+12,835% +$12M 0.19% 43
2014
Q3
$100K Sell
4,184
-7,268
-63% -$167K ﹤0.01% 3184
2014
Q2
$264K Sell
11,452
-464,682
-98% -$10.3M ﹤0.01% 2721
2014
Q1
$10.9M Buy
476,134
+442,914
+1,333% +$9.44M 0.14% 98
2013
Q4
$614K Sell
33,220
-810,180
-96% -$14.1M 0.01% 1724
2013
Q3
$14.3M Buy
+843,400
New +$14.2M 0.18% 64

Other funds holding NVO

Virtu KCG Holdings's NVO Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Novo Nordisk (NVO) stake by 33% in Q2 2017, selling an estimated $282K and leaving 28,478 shares worth $611K. The position accounts for 0.02% of the portfolio, ranked #959.

Virtu KCG Holdings first reported a position in NVO in Q3 2013 and has held it in 16 quarters since. The position peaked at $14.3M in Q3 2013. 484 funds tracked by Wall St. Rank hold NVO as of Q2 2017.

  • Virtu KCG Holdings held 28,478 shares of Novo Nordisk worth $611K as of Q2 2017.
  • Virtu KCG Holdings sold 13,992 Novo Nordisk shares in Q2 2017, an estimated $282K.
  • Novo Nordisk made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #959 holding.
  • Virtu KCG Holdings first reported a position in Novo Nordisk in Q3 2013 and has held it in 16 quarters since.
  • Virtu KCG Holdings's Novo Nordisk position peaked at $14.3M in Q3 2013.
  • 484 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.